These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 6332882

  • 1. Use of covalently bound cord factor analog to increase tumor immunogenicity.
    Eggers AE, Tarmin L, Ginsburg S.
    J Biol Response Mod; 1984 Aug; 3(4):413-22. PubMed ID: 6332882
    [Abstract] [Full Text] [Related]

  • 2. Chemical enhancement of tumor immunogenicity.
    Eggers AE, Hibbard CA, Civin CI, Wunderlich JR.
    J Immunol; 1980 Oct; 125(4):1737-44. PubMed ID: 6967915
    [Abstract] [Full Text] [Related]

  • 3. T cell nature of adjuvant peptide--induced antitumor cell-mediated cytotoxicity.
    Eggers AE, Tarmin L.
    J Biol Response Mod; 1984 Aug; 3(4):387-90. PubMed ID: 6332881
    [Abstract] [Full Text] [Related]

  • 4. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Dozmorov IM, Kuzin II, Lutsan NI, Lutsenko GV, Prokhorova AL, Sapozhnikov AM, Andronova TM, Ivanov VT.
    Biomed Sci; 1991 Aug; 2(6):651-8. PubMed ID: 1841635
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant.
    Chaitra MG, Nayak R, Shaila MS.
    Vaccine; 2007 Oct 10; 25(41):7168-76. PubMed ID: 17709160
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH, Gurish MF, Daynes RA.
    Immunology; 1982 Sep 10; 47(1):49-59. PubMed ID: 6981587
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Cytotoxic activity in the course of antitumoral cellular immunity].
    Firket H, Schaaf-Lafontaine N.
    Bull Mem Acad R Med Belg; 1978 Jul 15; 133(7):389-401. PubMed ID: 309778
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
    Minami A, Kasai M, Mizushima Y, Takeichi N, Hosokawa M, Kobayashi H.
    Cancer Res; 1980 Jul 15; 40(7):2129-34. PubMed ID: 6446378
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma].
    Gordienko SP, Bergol'ts VM.
    Vopr Onkol; 1973 Jul 15; 19(11):54-60. PubMed ID: 4785975
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.